IOBENGUANE (123I)

DRUG2 trials

Sponsors

Princess Maxima Center For Pediatric Oncology, Prinses Maxima Centrum voor Kinderoncologie B.V.

Conditions

(suspision on) Neuroblastomaneuroblastoma

Phase 1

A Prospective Study Comparing [18F]mFBG PET-CT to [123I]mIBG Scanning in Neuroblastoma

RecruitingCTIS2022-501694-39-01

Princess Maxima Center For Pediatric Oncology(suspision on) Neuroblastoma

Start: 2024-11-12Target: 58Updated: 2025-10-16

68Ga-SATO in paediatric neuroblastoma patients; exploratory, safety, non-randomized, open label, comparative study - GAP NBL study

RecruitingCTIS2024-513843-10-00

Prinses Maxima Centrum voor Kinderoncologie B.V.neuroblastoma

Start: 2023-02-28Target: 20Updated: 2025-06-17